New York, NY USA
Add to Favorites | Newsroom RSS | Share

Our News on Newswise

Cancer Research Institute Awards Grant to Develop Powerful Genomic Data Resource for Cancer Immunotherapy Researchers

Three nonprofits partner to create powerful database that will aim to improve immunotherapy for many types of cancer.
31-Jan-2017 6:00 AM EST Add to Favorites

ASH 2016: Tackling Blood Cancers with Immunotherapy

This Saturday [Dec 3], the 58th Annual Meeting of the American Society of Hematology will begin in San Diego, where the latest advances in research for blood cancers including leukemia, lymphoma, and myeloma will be highlighted during the four days...
12-Dec-2016 11:05 AM EST Add to Favorites

Cancer Research Institute and Fibrolamellar Cancer Foundation Announce Partnership to Fund Cancer Immunotherapy Research in Ultra-Rare Liver Cancer

Warning: Missing argument 7 for ArticlesHelper::linkArticleView(), called in /opt/newswise/trunk/src/app/views/institutions/newsroom.phtml on line 307 and defined in /opt/newswise/trunk/src/app/helpers/ArticlesHelper.php on line 36 Notice: Undefined variable: doe57url in /opt/newswise/trunk/src/app/helpers/ArticlesHelper.php on line 57
CRIlogo_RGB_notagline_400x170.png

Two nonprofits team up to fund immunotherapy research designed to benefit patients with an ultra-rare form of liver cancer.
6-Dec-2016 6:00 AM EST Add to Favorites

Parker Institute for Cancer Immunotherapy and Cancer Research Institute Launch Collaboration on Cancer Neoantigens

Warning: Missing argument 7 for ArticlesHelper::linkArticleView(), called in /opt/newswise/trunk/src/app/views/institutions/newsroom.phtml on line 307 and defined in /opt/newswise/trunk/src/app/helpers/ArticlesHelper.php on line 36 Notice: Undefined variable: doe57url in /opt/newswise/trunk/src/app/helpers/ArticlesHelper.php on line 57
parkerinstitutelogo.png

New collaboration between two nonprofits focused on cancer immunotherapy aims to identify new DNA-based targets for personalized cancer treatments
1-Dec-2016 6:00 AM EST Add to Favorites

Cancer Research Institute to Honor Amgen for Advancing Cancer Immunotherapy Treatments and Patient Education

Nonprofit devoted to cancer immunotherapy will honor the biotech company Amgen for its contributions to cancer immunotherapy treatment and patient education
29-Aug-2016 12:00 PM EDT Add to Favorites

Leading Cancer Research Organizations to Host Cancer Immunotherapy Conference

Four leading cancer research organizations will host a conference dedicated to the latest in cancer immunotherapy.
15-Aug-2016 12:05 PM EDT Add to Favorites

Leading Cancer Research Organizations to Host Cancer Immunotherapy Conference

Media are encouraged to register to attend the second annual International Cancer Immunotherapy Conference organized by the Cancer Research Institute, Association for Cancer Immunotherapy, European Academy of Tumor Immunology, and the American...
3-Aug-2016 12:00 PM EDT Add to Favorites

Cancer Research Institute to Honor Three Scientists for Outstanding Contributions to Cancer Immunotherapy Research

Announcement of winners of the 2016 William B. Coley and Frederick W. Alt Awards, celebrating key scientific contributions to the fields of immunology, tumor immunology (also known as immuno-oncology), and cancer immunotherapy.
26-Jul-2016 1:00 PM EDT Add to Favorites

Our Experts on Newswise

Expert Available for Commentary on Recent FDA Analysis of TNF Blockers

The FDA announced on Aug 4 2009 that tumor necrosis factor (TNF) blockers used in the treatment of immune disorders carry an increased risk of lymphoma and other cancers in children and adolescents. The discoverer of TNF-alpha, Lloyd J. Old, M.D., a...
7-Aug-2009 9:00 AM EDT

PROVENGE Cancer Vaccine Heralds New Dawn in Cancer Therapy

Dendreon's PROVENGE for the treatment of advanced prostate cancer is the first active cellular immunotherapy to prolong patient survival, according to data from a pivotal phase III clinical trial announced at yesterday's AUA annual meeting in...
29-Apr-2009 11:20 AM EDT

Our YouTube Videos





Chat now!